Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+
Clinical trial NCT06846463 · RECRUITING
Trial details
- NCT number
- NCT06846463
- Sponsor
- Virginia Commonwealth University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-27
- Primary completion
- 2029-07-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.